Stay updated on Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page
- ChecktodayChange DetectedThe page’s revision tag was updated from v3.5.4 to v3.5.5, indicating a newer revision of the page content.SummaryDifference0.0%

- Check8 days agoNo Change Detected
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedResults have been posted for the study, including ORR and PFS metrics with follow-up details and posting/submission dates. The page now shows the study as completed and adds related documents such as the Informed Consent Form and Study Protocol/Statistical Analysis Plan.SummaryDifference2%

- Check43 days agoChange DetectedThe page’s footer revision label was updated from **v3.5.2** to **v3.5.3**, reflecting a non-clinical version update of the page display.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. No substantive content changes to the study details are indicated by the provided inputs.SummaryDifference0.0%

- Check79 days agoChange DetectedRevision: v3.5.0 replaces the previous v3.4.3 on the page. No obvious changes to the study data or core content are indicated.SummaryDifference0.0%

- Check94 days agoChange DetectedRevision: v3.4.3 was added and Revision: v3.4.2 was removed.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and Radiation in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiation in Lung Cancer Clinical Trial page.